Back to 
Viking Global Investors LP
Viking Global Investors LP
AMRX
Showing 0 of 2 quarters
Position history for Viking Global Investors LP's holdings in Amneal Pharmaceuticals, Inc.
No. Viking Global Investors exited its AMRX (Amneal Pharmaceuticals) position in Q1 2019. Its Q4 2018 13F listed 2,353,204 shares worth $31.8M. Viking Global Investors already held AMRX in its Q4 2018 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.